当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析

福元医药

(601089)

  

流通市值:32.32亿  总市值:75.55亿
流通股本:2.05亿   总股本:4.80亿

福元医药(601089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.34亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益346125.58万元,未分配利润129208.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产449390.92万元,负债103265.34万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入802,722,388.573,339,636,352.622,462,880,582.111,629,808,705.94
营业总成本671,053,272.622,805,736,964.072,036,414,629.571,353,115,286.74
营业利润148,380,642.31552,009,967.45436,425,626.12286,552,022.6
利润总额148,027,971.25549,151,061.17436,514,235.17286,962,504.59
净利润133,524,586.6492,336,741.15383,031,171.23252,279,579.43
其他综合收益----
综合收益总额133,524,586.6492,336,741.15383,031,171.23252,279,579.43
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,207,420,793.263,328,740,564.813,285,610,287.833,269,446,812.63
非流动资产合计1,286,488,414.511,219,049,736.981,161,579,895.421,075,285,464.9
资产总计4,493,909,207.774,547,790,301.794,447,190,183.254,344,732,277.53
流动负债合计963,856,813.12998,375,562.87989,214,460.271,010,358,074.14
非流动负债合计68,796,569.8272,875,632.8793,088,957.0497,775,924.68
负债合计1,032,653,382.941,071,251,195.741,082,303,417.311,108,133,998.82
归属于母公司股东权益合计3,452,185,860.683,468,416,436.93,357,177,253.433,230,241,042.15
股东权益合计3,461,255,824.833,476,539,106.053,364,886,765.943,236,598,278.71
负债和股东权益合计4,493,909,207.774,547,790,301.794,447,190,183.254,344,732,277.53
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计863,597,324.973,309,139,215.242,457,630,041.471,657,994,428.4
经营活动现金流出小计719,714,280.452,753,238,603.142,043,525,474.51,376,271,927.45
经营活动产生的现金流量净额143,883,044.52555,900,612.1414,104,566.97281,722,500.95
投资活动现金流入小计8,571,117.5391,556,477.66387,662,878.04382,620,887.46
投资活动现金流出小计99,900,685.86777,213,230.61671,769,203.18541,833,012.48
投资活动产生的现金流量净额-91,329,568.36-385,656,752.95-284,106,325.14-159,212,125.02
筹资活动现金流入小计39,900,00055,000,00055,000,00055,000,000
筹资活动现金流出小计201,298,217.07261,682,820.72255,258,574.67247,687,437.64
筹资活动产生的现金流量净额-161,398,217.07-206,682,820.72-200,258,574.67-192,687,437.64
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-108,844,740.91-36,438,961.57-70,260,332.84-70,177,061.71
期末现金及现金等价物余额2,395,655,623.172,504,500,364.082,470,678,992.812,470,762,263.94
最新报告期:2024-05-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
浙商证券孙建,郭双喜0.871.001.282024-05-01
太平洋周豫1.171.431.672024-04-24
太平洋周豫1.171.431.672024-04-01
TOP↑